Leyden Laboratories B.V. (the "Company" or "Leyden Labs") today announced it has raised $70M in funding to advance its Mucosal Protection Platform. This non-vaccine approach utilizes broadly ...
Amsterdam-based Leyden Labs, a platform working to free people from the threat of respiratory viruses, announced Thursday that it has raised $70M (approximately €68M) in funding. The funding round was ...
A Dutch biotech creating nasal sprays to protect against the flu and coronavirus has raised an additional $70 million and acquired a nimble Singapore startup … ...
Credit: Aaron of L.A. Photography/Shutterstock Credit: Aaron of L.A. Photography/Shutterstock ...